HC Wainwright Cuts Earnings Estimates for Ocular Therapeutix
Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) - Research analysts at HC Wainwright lowered their Q1 2025 EPS estimates for Ocular Therapeutix in a report released on Tuesday, March 4th. HC Wainwright analyst Y. Chen now expects that the biopharmaceutical company will post earnings of ($0.3.
Publicado el: 2025-03-07 12:18:49
Autor: lulegacy, Fuente: lulegacy
Compartir: 
